The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes
Abstract
We have identified new activating receptors of the Ig superfamily expressed on human myeloid cells, called TREM (triggering receptor expressed on myeloid cells). TREM-1 is selectively expressed on blood neutrophils and a subset of monocytes and is up-regulated by bacterial LPS. Engagement of TREM-1 triggers secretion of IL-8, monocyte chemotactic protein-1, and TNF-alpha and induces neutrophil degranulation. Intracellularly, TREM-1 induces Ca2+ mobilization and tyrosine phosphorylation of extracellular signal-related kinase 1 (ERK1), ERK2 and phospholipase C-gamma. To mediate activation, TREM-1 associates with the transmembrane adapter molecule DAP12. Thus, TREM-1 mediates activation of neutrophil and monocytes, and may have a predominant role in inflammatory responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TREM2 expression was first observed in macrophages and dendritic cells, but not granulocytes or monocytes (9–11).”
From Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions (2020) · cites this paper as [9]
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 7,009
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,641
Recognition of Gram-negative bacteria and endotoxin by the innate immune system
Ulevitch, R. J., & Tobias, P. S. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80004-1 · Cited by 567
Cantoni, C., Bottino, C., Vitale, M., Pessino, A. M., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A., & Biassoni, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.787 · Cited by 450
Cella, M., Döhring, C., Samaridis, J., Dessing, M., Brockhaus, M., Lanzavecchia, A., & Colonna, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.10.1743 · Cited by 430
Bakker, A. B. H., Baker, E. G., Sutherland, G. R., Phillips, J. H., & Lanier, L. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9792 · Cited by 210
Nakajima, H., Samaridis, J., Ångman, L., & Colonna, M. (1999) · PubMed · Cited by 173
Dietrich, J., Cella, M., Seiffert, M., Bühring, H., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.9 · Cited by 172
Nakajima, H., Samaridis, J., Ångman, L., & Colonna, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.5 · Cited by 152
Kubagawa, H., Chen, C., Ho, L. H., Shimada, T., Gartland, L., Mashburn, C. B., Uehara, T., Ravetch, J. V., & Cooper, M. D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.309 · Cited by 148
Flagged first, then by citations
Research works printed but not linked: 13
- 1999, Curr. Opin. Immunol., 19
- 1995, Semin. Cell Biol., 345
- 1999, J. Immunol., 5
- 1998, J. Immunol., 4042
- 1999, J. Exp. Med., 309
- 2000, J. Immunol., 9
- 1999, Proc. Natl. Acad. Sci. USA, 9792
- 1998, Annu. Rev. Immunol., 359
- 1999, J. Exp. Med., 787
- 1991, Trends Biotechnol., 109
- 1997, J. Exp. Med., 1743
- 1997, The Leukocyte Antigen Facts Book
- 1994, Cell, 301
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Mason, D. Y., André, P., Bensussan, A., et al. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.5.685 · Cited by 5
Building up an infection control strategy based on the e-health concept
Palos, C., Pedroso, A., Mapril, J., & Alves, C. (2010) · Critical Care · doi:10.1186/cc9154 · Cited by 5
Clinical effects of adsorption of lipopolysaccharide in the treatment of Gram-negative severe sepsis
Кулабухов, В. В., Chizhov, A., Клеузович, А. А., & Kudryavtsev, A. N. (2010) · Critical Care · doi:10.1186/cc9131 · Cited by 5
Xu, Y., Fan, Y., Peng, J., Zhang, X., Luo, Q., Shui, K., Li, T., Qin, J., Zhang, H., Nie, R., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003836 · Cited by 6
Yao, R., Zhang, Y., Yu, W., Chen, X., Shi, H., Luo, R., Fang, C., Zhao, X., Zhu, X., Lai, Y., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120846 · Cited by 4
Li, Y., Wang, Y., Li, H., Gao, R., Zhang, W., & Yang, X. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112509 · Cited by 4
TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma
Gross, L., Mutisheva, I., Hillen, H., et al. (2025) · Molecular Therapy Oncology · doi:10.1016/j.omton.2025.201034 · Cited by 4
“24,25 Possible ligands for TREM-1 are either endogenous danger signals released by necrotic cells, such as HMGB1 and Hsp70, 26 or peptido-glycan (PGN) recognition protein 1 (PGLYRP1) complexed with PGN. 27 TREM-1 activation triggers an oxidative burst, 28,29 along with the release of…”
[Expression of TREM-1 in patients with invasive cervical cancer and precursor lesions].
Anaya‐Prado, R., Norzgaray-Ibarra, F. G., Bravo‐Cuéllar, A., et al. (2017) · PubMed · Cited by 4
Liu, M.-W., Huang, Y.-Q., Qu, Y.-P., et al. (2018) · International Journal of Immunopathology and Pharmacology · doi:10.1177/2058738418818630 · Cited by 4
IL-1R2-based biomarker models predict melioidosis mortality independent of clinical data
Kaewarpai, T., Wright, S. W., Yimthin, T., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1211265 · Cited by 4
Who is who within the universe of TREM-like transcripts (TREML)?
Ertel, M. V., da Silva, A. B. A., de Sousa, D. F., dos Santos, C. J., da Silva, T. M., Silva‐Sales, M., Matos, A. D. O., & Sales‐Campos, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122696 · Cited by 4
Could TREM-1 be a novel marker in the diagnosis of fibromyalgia?: A cross-sectional study
Baykara, R. A., Kıran, T. R., Otlu, Ö., Erdem, M., & Taş, N. P. (2024) · Medicine · doi:10.1097/md.0000000000038806 · Cited by 4
“[35] In many rheumatological diseases, the etiopathogenesis of which has been investigated immunologically and which can be treated with biological agents, TREM-1 levels have been detected to be higher compared to the control group.”
BackgroundLee, H. J., Shin, H. S., Jang, H. W., et al. (2014) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.4.960 · Cited by 4
Moriyama, M., Hirano, T., Kawano, T., Kadowaki, Y., Kodama, S., & Suzuki, M. (2018) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2018.06.025 · Cited by 4
Reduced Uterine Tissue Damage during Chlamydia muridarum Infection in TREM-1,3-Deficient Mice
McQueen, B., Kollipara, A., Gyorke, C. E., et al. (2021) · Infection and Immunity · doi:10.1128/iai.00072-21 · Cited by 4
de Jesus, M. C. S., Barbosa, J. H. R., Menezes, R. A. D. O., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270007 · Cited by 4
“Among these, the Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) is a receptor expressed in macrophages, monocytes, and neutrophils that is known to increase inflammatory responses of myeloid cells in innate and adaptive responses that were initiated by the Toll-like receptors [14, 15].”
BackgroundLiu, M., Wu, W., Zhao, Q. C., et al. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00057 · Cited by 4
Zhou, J., Zhou, J., Yan, H., et al. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.664801 · Cited by 4
Hall, S., Burns, G. S., Mooney, B. J., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac375 · Cited by 4
Kumar, V. (2012) · InTech eBooks · doi:10.5772/25590 · Cited by 4
Tobón, F. A. R., López, A. I. H., Osorno, S. C., & Barragán, F. A. J. (2007) · IATREIA · doi:10.17533/udea.iatreia.4404 · Cited by 4
The Pathophysiological Relevance of Monocyte-platelet Interactions in Inflammatory Disease
Stephen, J., & Dransfield, I. (2010) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2010.08.002 · Cited by 4
Sim, Y. S., Lee, J. H., Chun, E. M., et al. (2007) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2007.62.6.499 · Cited by 4
Role of Triggering Receptor Expressed on Myeloid Cells in the Activation of Innate Immunity
Геннадьевна, М. В., Головкин, А. С., Grigoryev, E. V., et al. (2011) · General Reanimatology · doi:10.15360/1813-9779-2011-3-70 · Cited by 4
Hu, C., Jiang, J., Li, Z., et al. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.03.41 · Cited by 4
Dal-Secco, D., Olivon, V. C., Corrêa, T., Celes, M., Abreu, M. V. A., Rossi, M., de Oliveira, A. L., Cunha, F. Q., & Assreuy, J. (2010) · Critical Care · doi:10.1186/cc9137 · Cited by 4
Metz‐Boutigue, M., Zhang, D., Lavaux, T., Schneider, F., & Aunis, D. (2010) · Critical Care · doi:10.1186/cc9135 · Cited by 4
Galley, H. F. (2006) · doi:10.1002/9780470755297.ch11 · Cited by 4
Roles of Triggering Receptor Expressed on Myeloid Cells-1: More than Just Pneumonia
Han, J., & Li, L. (2024) · Advances in Human Biology · doi:10.4103/aihb.aihb_173_22 · Cited by 3
A dual role for PGLYRP1 in host defense and immune regulation during B. pertussis infection
Rickert, D. M., Cardozo, S., Carbonetti, N. H., Goldman, W. E., Scanlon, K. M., & Skerry, C. M. (2026) · eLife · doi:10.7554/elife.108947.3 · Cited by 3
Quipildor, G. F., Belfiore, R., Althobaiti, K., Najarzadeh, Z., Glabe, C. C., Readhead, B. P., Gandy, S., Salton, S. R., & Ehrlich, M. E. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-025-00012-x · Cited by 6
Bosco, M. C., & Varesio, L. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9167-5_5 · Cited by 3
Sepsis-3: renewed determinations, potential problems and further practical foot steps
Кryvoruchko, І. А., Boyko, V. V., Іvanova, Y. V., et al. (2019) · Klinicheskaia khirurgiia · doi:10.26779/2522-1396.2019.06.60 · Cited by 3
Pathological Roles of INPP5D in Alzheimer’s Disease
Chu, Y. N., Akahori, A., Takatori, S., & Tomita, T. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-31978-5_30 · Cited by 3
Higher soluble TREM-1 levels are associated with cognitive impairment after acute ischemic stroke
Chen, Z., Yi, X., Fu, W., et al. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1463065 · Cited by 3
Yi, F., Wu, H., & Zhao, H. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i9.100312 · Cited by 3
Silbereisen, A., Lira‐Junior, R., Afacan, B., et al. (2025) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.14195 · Cited by 3
“…protein 1 (PGLYRP1), a neutrophil-derived bactericidal protein, is one of the ligands that can activate the TREM-1 signalling pathway, which works in synergy with Toll-like receptor activation (Bouchon et al. 2000; Dziarski and Gupta 2010; Nylund et al. 2018; Read et al. 2015; Tammaro et al. 2017).”
Zhou, X., Bi, J., Chen, H., Wang, Y., Li, Y., Huang, D., Ma, X., Cai, W., Jiang, D., & Guan, T. (2025) · The FASEB Journal · doi:10.1096/fj.202501934rr · Cited by 3
DNAX-Activating Protein of 12 kDa Impairs Host Defense in Pneumococcal Pneumonia
Hommes, T. J., Hoogendijk, A. J., Dessing, M. C., Veer, C. V. ′., Florquin, S., de Vos, A. F., & van der Poll, T. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000686 · Cited by 3
Integrating classifiers across datasets improves consistency of biomarker predictions for sepsis
Saraiva, J., Oswald, M., Biering, A., Assmann, C., Klassert, T. E., Blaess, M. F., Czakai, K., Claus, R. A., Löffler, J., Slevogt, H., et al. (2016) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2016.12.109 · Cited by 3
Human peptidoglycan recognition protein 1 in innate immunity
(2018) · Cogent Biology · doi:10.1080/23312025.2018.1450917 · Cited by 3
“Triggering receptor expressed on myeloid cells 1 (TREM-1) is expressed on neutrophils and most monocytes or macrophages constitutively and potently amplifies inflammation [20].”
BackgroundMontañez-Fernández, J. L., Cueto-Manzano, A. M., Campos, E. R., et al. (2021) · ASAIO Journal · doi:10.1097/mat.0000000000001541 · Cited by 3
Bomfim, L. G. S., Magalhães, L. S., Rodrigues, L. S., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.863986 · Cited by 3
Zhao, Y., Lv, H., Deng, X., et al. (2023) · Cell Cycle · doi:10.1080/15384101.2024.2302244 · Cited by 3
“TREM1, an immunoglobulin (Ig) superfamily receptor, is primarily expressed on myeloid cells regulating its differentiation through the release of inflammatory mediators [57].”
BackgroundExtracellular Cold-Inducible RNA-Binding Protein and Hemorrhagic Shock: Mechanisms and Therapeutics
Rashid, N., Hu, Z., Jacob, A., & Wang, P. (2024) · Biomedicines · doi:10.3390/biomedicines13010012 · Cited by 3
Li, R., Li, Q., Yang, C., Liu, H., Xiao, Y., Yang, P., Gong, G., & Wu, W. (2025) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2025.108280 · Cited by 3
Identification of early biomarkers in a rabbit model of primary Candida pneumonia
Lu, G., Wang, C., Wu, C., et al. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4320-9 · Cited by 3
Lu, Y., Yen, C.-Y., Ho, H., et al. (2006) · Hybridoma · doi:10.1089/hyb.2006.25.20 · Cited by 3
Physiopathologie du choc septique
Lemaout, C., Gonzalez, H., Aboab, J., & Annane, D. (2006) · La Presse Médicale · doi:10.1016/s0755-4982(06)74628-0 · Cited by 3
Keratinocytes and Activation of TREM-1 Pathway in Cutaneous Leishmaniasis Lesions
Nunes, S., Ampuero, M. R., Bonyek-Silva, Í., Lima, R., Lima, F. R., Arruda, S. M., Khouri, R., Oliveira, P. R. S., Barral, A. M. P., Boaventura, V. S., et al. (2021) · Microbiology Research · doi:10.3390/microbiolres12040056 · Cited by 3
“TREM-1 has emerged as a key molecule during inflammatory diseases, promoting complex effects on cells of the immune system and exacerbating the host response [7,8].”
BackgroundTREM-1 is required for enhanced OpZ-induced superoxide generation following priming
Murthy, S., Baruah, S., Bowen, J. L., Keck, K., Wagner, B. A., Buettner, G. R., Sykes, D. B., & Klesney-Tait, J. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0421-212r · Cited by 3
Dengue Virus Increases the Expression of TREM-1 and CD10 on Human Neutrophils
Ruiz‐Pacheco, J. A., Muñoz-Medina, E. J., Díaz, L., et al. (2023) · Viral Immunology · doi:10.1089/vim.2022.0124 · Cited by 3
“In turn, TREM-1 expression can be upregulated by invading pathogens or self-molecules, and differentially affected by cytokines (Bleharski et al, 2003; Bouchon et al, 2000; Wu et al, 2012).”
Signal Transduction Changes in fMLP, TLRs, TREM-1 and GM-CSF Receptors in PMN with Aging
Fortin, C. F., Larbi, A., Dupuis, G., & Fülöp, T. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_23 · Cited by 3
Mining metastasis related genes by primary-secondary tumor comparisons from large-scale databases
Kim, S., & Lee, D. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-s3-s2 · Cited by 3
“TREM2 (triggering receptor expressed on myeloid cells 2, 1405 metastasis score, 3rd ranked) is also known to have a role in chronic inflammations and stimulate production of constitutive chemokines and cytokines [19].”
BackgroundLa génétique de la maladie d’Alzheimer
Halla, S. B., Moutawakil, B. E., Kadmiri, N. E., & Nadifi, S. (2019) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2018.11.006 · Cited by 4
Chromogranin A expression in plasma of critically ill patients
Lavaux, T., Schneider, F., Bach, C., Herbrecht, J.-É., Aunis, D., & Metz-Boutigue, M. H. (2010) · Critical Care · doi:10.1186/cc9140 · Cited by 3
Sjövall, F., Morota, S., Hansson, M., Friberg, H., Gnaiger, E., & Elmér, E. (2010) · Critical Care · doi:10.1186/cc9114 · Cited by 3
Lourens, N. A., Bösenberg, L. H., Tintinger, G. R., et al. (2008) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e318167652d · Cited by 3
“tuberculosis (3), Pseudomonas aeruginosa (2), and Salmonella species (1).”
BackgroundDerive, M., Bouazza, Y., Massin, F., Alauzet, C., Lévy, B., Bollaërt, P., & Gibot, S. (2010) · Critical Care · doi:10.1186/cc9146 · Cited by 3
CCR2 drives neutrophil infiltration and elicits tissue damage in remote organs during sepsis
Souto, F., Alves‐Filho, J., Turato, W. M., Nascimento, D., Auxiliadora‐Martins, M., Basile-Filho, A., & Cunha, F. Q. (2010) · Critical Care · doi:10.1186/cc9126 · Cited by 3
Severity of illness scoring systems in community-acquired Legionella pneumonia
Simonsen, Ø., & Ringstad, J. (2010) · Critical Care · doi:10.1186/cc9128 · Cited by 3
Serum procalcitonin as a diagnostic tool of bacteremia
Gartzonika, C., Priavali, E., Zotos, N., Kallinteri, A., Katsoula, I., Sakkas, H., Papapetrou, E., Kapsali, E., Vrioni, G., Mavridis, A. K., et al. (2010) · Critical Care · doi:10.1186/cc9117 · Cited by 3
Parente, J. D., Lee, D., Lin, J., Chase, J. G., & Shaw, G. (2010) · Critical Care · doi:10.1186/cc9116 · Cited by 3
Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancerPreprint
Costa, D. B. V., Francescone, R., Franco‐Barraza, J., Luong, T., Graves, M., de Aquino, A. M., Steele, N. G., Gardiner, J. C., dos Santos, S. A. A., Ogier, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.15.594354 · Cited by 3
Two Genes Behind PLOSL : Molecular and Pathological Characteristics of the Disease
Paloneva, J. (2003) · Työväentutkimus Vuosikirja · Cited by 3
TREM-1 as a Marker of Multiple Organ Failure in Cardiac Surgery
Khutornaya, M. V., Sinitsky, M. Y., Sinitskaya, А. V., et al. (2023) · Immunological Investigations · doi:10.1080/08820139.2023.2215276 · Cited by 2
“TREM-1 was described in 2000 by Bouchon and colleagues in the context of septic shock pathophysiology (Bouchon et al. 2000) and has been primarily reported as an informative marker of sepsis (Oku et al.”
BackgroundZhong, W., Xiong, J., Zhang, C., et al. (2025) · Histochemistry and Cell Biology · doi:10.1007/s00418-025-02374-5 · Cited by 2
“These findings suggest that AEC senescence is a pivotal factor in the pathogenesis of PF. TREM-1 is expressed mainly on the surface of myeloid cells such as neutrophils or monocytes/ macrophages (Bouchon et al. 2000).”
Silva-Neto, P. V. D., de Carvalho, J. C. S., Toro, D. M., Oliveira, B., Cominal, J. G., Castro, R. C., Almeida, M., Prado, C. M., Arruda, E., Frantz, F. G., et al. (2025) · Viruses · doi:10.3390/v17050610 · Cited by 2
“During SARS-CoV-2 infection, TREM-1 activation exacerbates acute inflammation, contributes to tissue damage, and intensifies the cytokine storm [8–10].”
Awan, M. N., Albaqami, F. F., Nadeem, H., Zulfiqar, I., Rehman, N. U., Ayaz, M., Khan, M. F., & Shah, F. A. (2025) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.70051 · Cited by 2
Sigalov, A. B. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1689771 · Cited by 2
Theobald, V., Gregorius, J., Berger, M. M., Decker, S., Feißt, M., Herbstreit, F., Nußhag, C., Skarabis, A., Schmidt, K. D., Schmitt, F. C. F., et al. (2026) · Critical Care · doi:10.1186/s13054-026-06025-6 · Cited by 3
“Consistently, TREM-1 was first found to be expressed on the surface of monocytes and neutrophils [11], but it is also expressed on non-immune cells like hepatic endothelial cells and gastric epithelial cells.”
The role of DAP12 in immune-related inflammatory diseases
Lu, J., Shi, L., Jin, G., Yang, Y., Zhu, F., & Zhou, G. (2026) · Inflammation Research · doi:10.1007/s00011-026-02256-z · Cited by 3
Revisiting TREM2: from multi-omics signaling networks to clinical translation
Yang, J., Wan, D., Ren, L., Lv, Y., & Zhao, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1782384 · Cited by 2
EFFECTS OF MYOCARDIAL CYTOSOLIC FRACTION AND LIPOPOLYSACCHARIDE UPON MONOCYTIC FUNCTIONS
Матвеева, В. Г., Головкин, А. С., Chernova, M. N., et al. (2014) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2013-5-439-448 · Cited by 2
Toxicogenomic Approach to Risk Assessment of Welding Fumes
Rim, K.-T. (2012) · Journal of Clinical Toxicology · doi:10.4172/2161-0495.s5-004 · Cited by 2
“It has been reported that treating macrophages with an agonistic Trem1 antibody induces the activation of recognition receptors, such as the TLR or NLR family, and increases cytokine and chemokine secretion [8,9].”
BackgroundYasin, H. M. M., Aly, N. K., & Abdelaziz, S. Y. (2020) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2020.67677 · Cited by 2
Zysset, D., Montani, M., Spalinger, J. H., et al. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000361 · Cited by 2
“In addition, in our cohort, the pediatric IBD samples showed significantly increased CXCL8 mRNA levels in comparison with non-IBD control samples.”
BackgroundInfluentialRegulation of TREM1-Mediated Inflammation in Hepatocellular Carcinoma Cells
Rai, V., & Agrawal, D. K. (2021) · Reports — Medical Cases Images and Videos · doi:10.3390/reports4020017 · Cited by 2
“TREM-1 is a transmembrane glycoprotein belonging to the immunoglobulin superfamily and family related to the natural killer cell receptor, expressed on monocytes, neutrophils, macrophages, and fibroblasts [16,17].”
BackgroundShen, P., Zhang, T., Chen, G., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112826 · Cited by 2
Li, P., Wang, R., Dong, W., Wang, G., Zhang, A., Chen, H., & Tan, C. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106535 · Cited by 2
Ruskin, P., Pandi, C., Kannan, B., Pandi, A., Girija, A. S. S., Jayaseelan, V. P., & Arumugam, P. (2024) · Cureus · doi:10.7759/cureus.64640 · Cited by 2
“Certain other inflammatory disorders such as pancreatitis, gastric ulcers, psoriasis, ulcerative colitis, and vasculitis situations when TREM1 may be over-expressed [9,27-29].”
BackgroundWan, J., Yang, F., Tong, S., Zhou, T., & Wang, S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113274 · Cited by 2
Immune Sensors, Regulators, and Effectors of Brain Health
Acıoğlu, Ç., & Elkabes, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_3 · Cited by 2
Could Be Systems-Directed Therapy Approaches Promising in Glioblastoma Patients?
Grauer, O. M., & Hau, P. (2010) · Springer eBooks · doi:10.1007/978-90-481-9531-2_8 · Cited by 2
Epithelial to Mesenchymal Transition in Microbial Pathogenesis
Chargui, A., Sanda, M., Brest, P., Hofman, P. M., & Valrie, V.-C. (2012) · InTech eBooks · doi:10.5772/34135 · Cited by 2
Lyar Is a New Ligand for Retinal Pigment Epithelial Phagocytosis
Guo, F., Ding, Y., Caberoy, N. B., Alvarado, G., Liu, R., Shen, C., Yu, J., Zhou, Y., Salero, E., LeBlanc, M. E., et al. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25089 · Cited by 2
“Despite identification of TREM2 as a phagocytic receptor 14 years ago [Bouchon et al., 2000], its ligand(s) remains elusive.”
Biomarkers in fever and neutropenia: A solution in search of a problem?*
Gea‐Banacloche, J. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31820f6d6d · Cited by 2
Diagnostic non bactériologique des pneumopathies acquises sous ventilation mécanique
Gibot, S., & Bollaert, P. (2005) · Réanimation · doi:10.1016/j.reaurg.2005.03.007 · Cited by 2
“Son expression est spécifiquement up-régulée à la surface des phagocytes en cas d’agression bactérienne [47,48].”
Maladies démyélinisantes d’origine génétique
Labauge, P. M., & Boespflug‐Tanguy, O. (2010) · La Presse Médicale · doi:10.1016/j.lpm.2009.11.011 · Cited by 2
Reitz, C., & Tosto, G. (2013) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000060 · Cited by 2
“The TREM2 gene istranslated into a type-I membrane protein with an extracellular Iglike domain and was first described as potentially involved in chronic inflammation response [49].”
Background[Role of triggering receptor expressed on myeloid cells-1 in the pathogenesis of Kawasaki disease].
Zhao, J., & Wang, Q. (2016) · PubMed · doi:10.7499/j.issn.1008-8830.2016.06.011 · Cited by 2
Expression of TREM-1 in maternal leukocytes in preterm, prelabour rupture of the membranes
Anaya‐Prado, R., Barba-Anaya, M. F., Sánchez-González, J. M., Anaya-Fernandez, M. M., Zavalza-Gómez, A. B., Gil-Villarreal, F., Bravo‐Cuéllar, A., & Grijalva-Solis, A. D. C. (2016) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2016.1217834 · Cited by 2
“Since TREM-1 has been identified as a the first activator in the inflammatory response and different studies have demonstrated that the expression of this molecule is directly proportional to the degree of inflammation and inversely proportional to the final prognosis of different acute processes, it could be interest…”
BackgroundInfluentialNew markers in prognosis of severe community-acquired pneumonia
Borovac, D. N., Pejčić, T., Petković, T., et al. (2011) · Cited by 2
Nishikawa, M., Iwaki, M., Tashiro, K., & Kurose, K. (2020) · Xenobiotica · doi:10.1080/00498254.2020.1767320 · Cited by 2
THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES
Kutlu, Y., Toprak, İ. D., Gökden, Y., et al. (2021) · Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi · doi:10.26650/iuitfd.2020.0090 · Cited by 2
Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00001-7 · Cited by 2
El-Sheikh, M. R., Elmahdy, H. S., Nassar, M. A. E., et al. (2022) · Pediatric Pulmonology · doi:10.1002/ppul.26016 · Cited by 2
“As one of the immunoglobulin super receptor family (Ig‐superfamily, Ig‐SF), sTREM‐1 induces chemokines and releases proinflammatory cytokines during acute infection.(20) The sTREM‐1 levels can increase in MV even without VAP due to the MV‐induced lung injury.”
BackgroundThe Macrophages and Intestinal Symbiosis
Kloc, M., Uosef, A., Elshawwaf, M., Abdelshafy, A. A. A., Elsaid, K. M., Kubiak, J. Z., & Ghobrial, R. M. (2020) · Results and problems in cell differentiation · doi:10.1007/978-3-030-51849-3_23 · Cited by 2
Daws (2001) · doi:10.1002/1521-4141(200103)31:3
Kalina (2002) · doi:10.1002/1521-4141(200209)32:9
Metadata
- Authors
- Bouchon, A., Dietrich, J., & Colonna, M.
- Affiliations
- Basel Institute for Immunology , Basel ,
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-05
- Volume
- 164
- Issue
- 10
- Pages
- 4991-4995
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2149698238
- Semantic Scholar
- c6fffd66acdcb27c928605f7aca443056a3a6c3f
- Cited by
- 1,284
- References
- 13
- Citations by year
- 2026: 38 · 2025: 47 · 2024: 73 · 2023: 87 · 2022: 51 · 2021: 65 · 2020: 83 · 2019: 49 · 2018: 55 · 2017: 51 · 2016: 59 · 2015: 47 · 2014: 48 · 2013: 68 · 2012: 50
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- TREM-1, neutrophils, monocytes, inflammation, IL-8 secretion, MCP-1, TNF-α, neutrophil degranulation, calcium mobilization, phospholipase C-gamma, myeloid cell activation
- MeSH terms
- Triggering Receptor Expressed on Myeloid Cells-1, Amino Acid Sequence, Fungi, Multigene Family, Gram-Negative Bacteria, Gram-Positive Bacteria, Humans, Immunoglobulins, Inflammation, Macrophage Activation, Membrane Glycoproteins, Membrane Proteins, Molecular Sequence Data, Molecular Weight, Monocytes, Neutrophils, Phosphorylation, Receptors, Immunologic, Tyrosine, Biomarkers, Up-Regulation, Cytokines, Neutrophil Activation, Chemokines, Calcium Signaling, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review